A phase I clinical trial of bavituximab and paclitaxel in patients with HER2 negative metastatic breast cancer

Cell-Derived Microparticles: New Targets in the Therapeutic Management of Disease

(2016) Mary Bebawy et al.   JOURNAL OF PHARMACY AND PHARMACEUTICAL SCIENCES

TIMgenes: a family of cell surface phosphatidylserine receptors that regulate innate and adaptive immunity

(2015) Gordon J. Freeman et al.   IMMUNOLOGICAL REVIEWS

Breast cancer statistics, 2013

(2013) Carol DeSantis et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Phosphatidylserine-Targeting Antibody Induces M1 Macrophage Polarization and Promotes Myeloid-Derived Suppressor Cell Differentiation

(2013) Y. Yin et al.   Cancer Immunology Research

Dynamic changes of live/apoptotic circulating tumour cells as predictive marker of response to Sunitinib in metastatic renal cancer

(2012) E Rossi et al.   BRITISH JOURNAL OF CANCER

Phase I Safety and Pharmacokinetic Study of Bavituximab, a Chimeric Phosphatidylserine-Targeting Monoclonal Antibody, in Patients with Advanced Solid Tumors

(2011) D. E. Gerber et al.   CLINICAL CANCER RESEARCH

Receptor for advanced glycation end products binds to phosphatidylserine and assists in the clearance of apoptotic cells

(2011) Mei He et al.   EMBO REPORTS

Clinical significance of circulating microparticles for venous thromboembolism in cancer patients

(2011) J. Thaler et al.   Hamostaseologie

Development of bavituximab, a vascular targeting agent with immune-modulating properties, for lung cancer treatment

(2011) Paul DeRose et al.   Immunotherapy

RIBBON-1: Randomized, Double-Blind, Placebo-Controlled, Phase III Trial of Chemotherapy With or Without Bevacizumab for First-Line Treatment of Human Epidermal Growth Factor Receptor 2–Negative, Locally Recurrent or Metastatic Breast Cancer

(2011) Nicholas J. Robert et al.   JOURNAL OF CLINICAL ONCOLOGY

All circulating EpCAM+CK+CD45- objects predict overall survival in castration-resistant prostate cancer

(2010) F. A. W. Coumans et al.   ANNALS OF ONCOLOGY

M30 Neoepitope Expression in Epithelial Cancer: Quantification of Apoptosis in Circulating Tumor Cells by CellSearch Analysis

(2010) E. Rossi et al.   CLINICAL CANCER RESEARCH

Phase III Study of Bevacizumab Plus Docetaxel Compared With Placebo Plus Docetaxel for the First-Line Treatment of Human Epidermal Growth Factor Receptor 2–Negative Metastatic Breast Cancer

(2010) David W. Miles et al.   JOURNAL OF CLINICAL ONCOLOGY

Microparticles in Cancer

(2010) Janusz Rak   SEMINARS IN THROMBOSIS AND HEMOSTASIS

Microparticles, thrombosis and cancer

(2009) Anat Aharon et al.   BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY

Antiphosphatidylserine Antibody Combined with Irradiation Damages Tumor Blood Vessels and Induces Tumor Immunity in a Rat Model of Glioblastoma

(2009) J. He et al.   CLINICAL CANCER RESEARCH

A phase II trial of single agent bevacizumab in patients with relapsed, aggressive non-Hodgkin lymphoma: Southwest oncology group study S0108

(2009) Alison T. Stopeck et al.   LEUKEMIA & LYMPHOMA

Increased microparticle tissue factor activity in cancer patients with Venous Thromboembolism

(2009) David A. Manly et al.   THROMBOSIS RESEARCH

Vascular Imaging of Solid Tumors in Rats with a Radioactive Arsenic-Labeled Antibody that Binds Exposed Phosphatidylserine

(2008) M. Jennewein et al.   CLINICAL CANCER RESEARCH

Mechanisms of Thrombus Formation

(2008) Bruce Furie et al.   NEW ENGLAND JOURNAL OF MEDICINE

Chemotherapy-Induced Thrombosis: A Role for Microparticles and Tissue Factor?

(2008) Daniel Lechner et al.   SEMINARS IN THROMBOSIS AND HEMOSTASIS